Viridian Therapeutics, Inc. VRDN Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s net change in cash?
- Viridian Therapeutics, Inc. (VRDN) reported net change in cash of -$36.04M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s net change in cash changed year-over-year?
- Viridian Therapeutics, Inc.'s net change in cash decreased by 316.8% year-over-year, from $16.62M to -$36.04M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s net change in cash?
- Over 2 years (2021 to 2025), Viridian Therapeutics, Inc.'s net change in cash has grown at a 459.9% compound annual growth rate (CAGR), from -$3.6M to $112.79M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.